Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 837,596
  • Shares Outstanding, K 41,200
  • Annual Sales, $ 354,000 K
  • Annual Income, $ -30,690 K
  • 60-Month Beta 1.66
  • Price/Sales 2.28
  • Price/Cash Flow 26.81
  • Price/Book 3.00
Trade AORT with:

Options Overview Details

View History
  • Implied Volatility 59.77% ( +1.38%)
  • Historical Volatility 35.62%
  • IV Percentile 73%
  • IV Rank 58.78%
  • IV High 101.20% on 10/30/23
  • IV Low 0.71% on 09/21/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 33
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 824
  • Open Int (30-Day) 1,183

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.02
  • Number of Estimates 1
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.02
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.36 +5.01%
on 05/01/24
21.90 -7.17%
on 04/09/24
-0.86 (-4.06%)
since 04/01/24
3-Month
16.48 +23.33%
on 02/06/24
21.90 -7.17%
on 04/09/24
+3.31 (+19.45%)
since 02/01/24
52-Week
12.16 +67.21%
on 10/30/23
21.90 -7.17%
on 04/09/24
+6.29 (+44.80%)
since 05/01/23

Most Recent Stories

More News
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2023...

AORT : 20.33 (+3.62%)
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its On-X...

AORT : 20.33 (+3.62%)
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today presented interim results from the...

AORT : 20.33 (+3.62%)
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at...

AORT : 20.33 (+3.62%)
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present...

AORT : 20.33 (+3.62%)
Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

AORT : 20.33 (+3.62%)
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2023...

AORT : 20.33 (+3.62%)
Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and...

AORT : 20.33 (+3.62%)
BAX : 39.22 (-2.77%)
Artivion (AORT) Q1 Earnings and Revenues Beat Estimates

Artivion (AORT) delivered earnings and revenue surprises of 166.67% and 2.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AORT : 20.33 (+3.62%)
RWLK : 1.0501 (+6.07%)
Artivion Reports First Quarter 2023 Financial Results

First Quarter and Recent Business Highlights: Achieved revenue of $83.2 million in the first quarter of 2023 versus $77.2 million in the first quarter of 2022,...

AORT : 20.33 (+3.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 22.64
2nd Resistance Point 21.79
1st Resistance Point 21.06
Last Price 20.33
1st Support Level 19.48
2nd Support Level 18.63
3rd Support Level 17.90

See More

52-Week High 21.90
Last Price 20.33
Fibonacci 61.8% 18.18
Fibonacci 50% 17.03
Fibonacci 38.2% 15.88
52-Week Low 12.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar